Ładuje się......
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death in a proportion of patients. Among other fact...
Zapisane w:
| Wydane w: | Clin Appl Thromb Hemost |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publications
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7370334/ https://ncbi.nlm.nih.gov/pubmed/32677459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029620938149 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|